Built for your ascent
Accelagen is your smart launchpad, combining Australia’s strategic advantage with regulatory foresight and senior oversight to help biotech and pharma teams reach critical data and financing milestones with predictable progress.
Intelligence that travels
From day one, we align to global expectations, ground timelines in realistic planning, and anticipate risk early. Experienced minds remain engaged, ownership is visible, and contribution deepens as complexity grows, delivering predictable progress that stands up under scrutiny. As your program advances, we stay close and protect your momentum.


Founded in 2010, Accelagen was borne out of Greg and Rosa Plunkett’s passion and career as values-driven, outcome-focussed regulatory affairs and clinical development professionals. From the outset, Accelagen has a demonstrated track record delivering services beyond a simple transaction. We focus on your end goal and design the right strategy to get you there faster, whilst contributing to our collective mission, to create a difference to the future of human health.
Employing our unique approach to people and process, we work side by side with our partners to co-create meaningful outcomes with a tangible impact on the future of human health.
We offer strategic direction and consultation from concept through to commercialisation. We prioritise understanding where you are on your journey and the broader context of impact you hope to have.
Our process is collaborative and patient-centred. It draws upon our extensive industry experience and supports you to deliver a comprehensive and robust product to market, faster.
It’s this unique and innovative approach that creates a marked difference in the outcomes we generate for you.
Our values guide how we partner with sponsors, navigate complexity, and deliver meaningful progress for human health.

Our specialist and diverse team blends expert skills in clinical development and regulatory affairs management to accelerate our partners’ ability to bring their therapies and devices to market.

Latest company news
Ready to partner with a team invested in your success?
Connect with us today to discuss your program.

